Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/3300

TDMS Study 05121-07 Pathology Tables

NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96
Route: GAVAGE                                                                                                     Time: 22:04:18




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  6533-68-2

       Lock Date:  06/01/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All




































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          70           60           70           70           70                        

  Scheduled Sacrifice                                 10           10           10           10           10                        
  Early Deaths                                                                                                                      
    Natural Death                                      7            3            3            5            6                        
    Moribund Sacrifice                                 9           10           11            7            7                        
    Dosing Accident                                    2            1                         1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                33           36           36           37           38                        

  Animals Examined Microscopically                    61           60           60           60           61                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (61)         (60)         (60)         (60)         (60)                      
      Perforation                                      1 (2%)       1 (2%)                                                          
      Periesophageal Tissue, Inflammation,                                                                                          
          Suppurative                                  3 (5%)       1 (2%)       1 (2%)       2 (3%)                                
   Intestine Large, Rectum                            (61)         (60)         (60)         (60)         (60)                      
      Inflammation, Chronic Active                                                                         1 (2%)                   
   Intestine Small, Duodenum                          (61)         (60)         (59)         (60)         (61)                      
      Ulcer                                                                      1 (2%)                                             
   Intestine Small, Jejunum                           (61)         (58)         (59)         (60)         (60)                      
      Hyperplasia, Lymphoid                            2 (3%)       2 (3%)       1 (2%)                    3 (5%)                   
      Inflammation, Chronic Active                                  1 (2%)                    1 (2%)                                
      Ulcer                                                                                   1 (2%)                                
   Liver                                              (61)         (60)         (60)         (60)         (61)                      
      Angiectasis                                      1 (2%)       2 (3%)       1 (2%)       1 (2%)       1 (2%)                   
      Basophilic Focus                                 1 (2%)       1 (2%)       2 (3%)       4 (7%)       3 (5%)                   
      Clear Cell Focus                                              1 (2%)       1 (2%)                                             
      Developmental Malformation                                                 1 (2%)                                             
      Ectopic Tissue                                                1 (2%)                                                          
      Eosinophilic Focus                              17 (28%)      4 (7%)      10 (17%)     13 (22%)      9 (15%)                  
      Fatty Change                                                  1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                              1 (2%)       1 (2%)       1 (2%)       1 (2%)                   
      Inflammation                                                                                         1 (2%)                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mixed Cell Focus                                 7 (11%)      1 (2%)       7 (12%)      3 (5%)       3 (5%)                   
      Necrosis                                                      3 (5%)       1 (2%)       2 (3%)       2 (3%)                   
      Kupffer Cell, Pigmentation, Hemosiderin                                                 1 (2%)                                
   Mesentery                                          (7)          (5)          (9)          (4)          (5)                       
      Inflammation, Suppurative                                     2 (40%)                                                         
      Artery, Inflammation, Chronic Active                                                    1 (25%)                               
      Fat, Necrosis                                    6 (86%)      1 (20%)      8 (89%)      2 (50%)      2 (40%)                  
   Pancreas                                           (61)         (60)         (60)         (60)         (61)                      

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Atrophy                                          6 (10%)      4 (7%)       4 (7%)       4 (7%)                                
      Hypertrophy                                      1 (2%)                                                                       
      Inflammation, Chronic Active                                               2 (3%)                                             
      Duct, Cyst                                       2 (3%)       3 (5%)       4 (7%)       1 (2%)                                
   Salivary Glands                                    (60)         (60)         (60)         (60)         (61)                      
      Atrophy                                                       1 (2%)                                                          
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
      Duct, Hyperplasia                                1 (2%)                                                                       
   Stomach, Forestomach                               (61)         (60)         (60)         (60)         (61)                      
      Cyst                                                          1 (2%)                                                          
      Diverticulum                                                                                         1 (2%)                   
      Hyperplasia, Focal                               8 (13%)     17 (28%)      3 (5%)      12 (20%)     14 (23%)                  
      Infiltration Cellular, Plasma Cell                                                      1 (2%)                                
   Stomach, Glandular                                 (61)         (60)         (60)         (60)         (61)                      
      Erosion                                          2 (3%)       2 (3%)                                                          
      Mineralization                                                1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (61)         (58)         (60)         (60)         (61)                      
      Mineralization                                                1 (2%)                                                          
      Aorta, Inflammation, Chronic Active              1 (2%)                                 1 (2%)                                
   Heart                                              (61)         (60)         (60)         (60)         (61)                      
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   2 (3%)       1 (2%)                    1 (2%)                                
      Artery, Inflammation, Chronic Active                                                    1 (2%)       2 (3%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (61)         (60)         (60)         (60)         (61)                      
      Accessory Adrenal Cortical Nodule                1 (2%)       2 (3%)                    2 (3%)       1 (2%)                   
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hyperplasia                                      1 (2%)                    1 (2%)       4 (7%)       1 (2%)                   
      Capsule, Hyperplasia, Adenomatous                                          1 (2%)                                             
   Adrenal Medulla                                    (61)         (58)         (59)         (59)         (60)                      
      Hyperplasia                                      3 (5%)       1 (2%)                    2 (3%)                                
   Islets, Pancreatic                                 (61)         (60)         (60)         (60)         (61)                      
      Hyperplasia                                      1 (2%)       1 (2%)       2 (3%)                    1 (2%)                   
   Parathyroid Gland                                  (58)         (48)         (48)         (46)         (53)                      
      Cyst                                             1 (2%)                                                                       
      Cytoplasmic Alteration, Focal                                 1 (2%)                                                          
      Inflammation, Chronic Active                                                            1 (2%)                                
   Pituitary Gland                                    (60)         (58)         (57)         (57)         (56)                      
      Angiectasis                                                                1 (2%)       1 (2%)                                
      Pars Distalis, Hyperplasia                      27 (45%)     11 (19%)     15 (26%)     11 (19%)     14 (25%)                  

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Intermedia, Hyperplasia                                                                         1 (2%)                   
   Thyroid Gland                                      (61)         (60)         (59)         (60)         (61)                      
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                    5 (8%)       1 (2%)                   
      Follicular Cell, Hyperplasia                    18 (30%)      5 (8%)      14 (24%)     10 (17%)      8 (13%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (58)         (60)         (56)         (58)         (58)                      
      Duct, Ectasia                                                 1 (2%)       1 (2%)                    1 (2%)                   
   Ovary                                              (61)         (59)         (59)         (59)         (61)                      
      Cyst                                            17 (28%)     10 (17%)     17 (29%)     12 (20%)     14 (23%)                  
      Inflammation, Suppurative                                     2 (3%)       1 (2%)                    1 (2%)                   
      Mineralization                                                             1 (2%)                                             
   Uterus                                             (61)         (60)         (60)         (60)         (61)                      
      Angiectasis                                                                1 (2%)       2 (3%)                                
      Hyperplasia, Cystic                             43 (70%)     29 (48%)     37 (62%)     34 (57%)     27 (44%)                  
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       1 (2%)                                             
      Thrombosis                                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (61)         (60)         (60)         (60)         (61)                      
      Myelofibrosis                                   23 (38%)     18 (30%)     23 (38%)     15 (25%)     13 (21%)                  
      Erythroid Cell, Hyperplasia                      3 (5%)       2 (3%)       3 (5%)       4 (7%)                                
      Myeloid Cell, Hyperplasia                        9 (15%)      7 (12%)      5 (8%)       6 (10%)      3 (5%)                   
   Lymph Node                                         (6)          (3)          (5)          (4)          (3)                       
      Bronchial, Inflammation, Chronic Active                       1 (33%)                                                         
      Mediastinal, Hyperplasia, Lymphoid                                                      1 (25%)                               
      Renal, Angiectasis                                                         1 (20%)                                            
   Lymph Node, Mandibular                             (59)         (57)         (55)         (58)         (61)                      
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)                    1 (2%)                   
   Lymph Node, Mesenteric                             (60)         (57)         (56)         (59)         (58)                      
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)       1 (2%)       2 (3%)                   
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Spleen                                             (61)         (60)         (60)         (60)         (61)                      
      Depletion Lymphoid                               2 (3%)       1 (2%)                                                          
      Hematopoietic Cell Proliferation                17 (28%)     11 (18%)     11 (18%)     17 (28%)      7 (11%)                  
      Hyperplasia, Lymphoid                            3 (5%)       2 (3%)                    2 (3%)       2 (3%)                   
      Hyperplasia, Plasma Cell                         1 (2%)                                                                       

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Thymus                                             (57)         (53)         (53)         (56)         (55)                      
      Atrophy                                          3 (5%)       2 (4%)       7 (13%)      4 (7%)       3 (5%)                   
      Inflammation, Chronic Active                                                                         1 (2%)                   
      Mineralization                                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (61)         (59)         (59)         (60)         (61)                      
      Hyperplasia                                      1 (2%)                    3 (5%)       2 (3%)       4 (7%)                   
   Skin                                               (61)         (60)         (60)         (60)         (61)                      
      Cyst Epithelial Inclusion                                                                            1 (2%)                   
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Ulcer                                            1 (2%)                                                                       
      Subcutaneous Tissue, Fibrosis, Chronic Active                              1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (61)         (60)         (60)         (60)         (61)                      
      Infarct                                          1 (2%)                                                                       
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
      Neuron, Necrosis                                 1 (2%)       4 (7%)       1 (2%)                    2 (3%)                   
   Peripheral Nerve                                   (2)          (2)          (2)                                                 
      Degeneration                                     2 (100%)     1 (50%)      1 (50%)                                            
   Spinal Cord                                        (2)          (2)          (2)                       (1)                       
      White Matter, Degeneration                                                 1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (61)         (60)         (60)         (60)         (61)                      
      Inflammation, Chronic Active                     2 (3%)                    2 (3%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    1 (2%)                                             
   Trachea                                            (61)         (60)         (60)         (60)         (61)                      
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                             (1)                                                              
      Internal Ear, Inflammation, Chronic Active                    1 (100%)                                                        
   Eye                                                (2)                       (2)          (2)                                    
      Degeneration                                                               1 (50%)      1 (50%)                               
      Cornea, Inflammation, Chronic Active             2 (100%)                                                                     
      Lens, Cataract                                                                          1 (50%)                               
      Retina, Atrophy                                                                         1 (50%)                               
   Harderian Gland                                    (18)         (10)         (15)         (16)         (16)                      
      Inflammation, Chronic Active                                               1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (61)         (60)         (60)         (60)         (61)                      
      Cyst                                             1 (2%)                                                                       
      Infarct                                          1 (2%)                                                                       
      Inflammation, Chronic Active                                                                         1 (2%)                   
      Mineralization                                                1 (2%)                                                          
      Nephropathy                                     28 (46%)     25 (42%)     24 (40%)     27 (45%)     12 (20%)                  
      Artery, Inflammation, Chronic Active                                       1 (2%)       1 (2%)       1 (2%)                   
      Renal Tubule, Necrosis, Acute                    1 (2%)                                                                       
   Urinary Bladder                                    (60)         (60)         (58)         (59)         (61)                      
      Inflammation, Chronic Active                                                                         1 (2%)                   
      Artery, Inflammation, Chronic Active                                                    2 (3%)       1 (2%)                   
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          70           60           70           70           70                        

  Scheduled Sacrifice                                 10           10           10           10           10                        
  Early Deaths                                                                                                                      
    Natural Death                                      6            6            4            5            2                        
    Moribund Sacrifice                                 4            2            7            4            7                        
    Dosing Accident                                                 1                                      1                        
    Accidently Killed                                                                         2            1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                40           41           39           39           39                        

  Animals Examined Microscopically                    60           60           60           60           60                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (60)         (60)         (60)         (60)         (60)                      
      Cyst                                             1 (2%)                                                                       
      Periesophageal Tissue, Inflammation,                                                                                          
          Suppurative                                  1 (2%)       2 (3%)                                 1 (2%)                   
   Gallbladder                                        (59)         (60)         (59)         (59)         (58)                      
      Inflammation, Chronic Active                                               1 (2%)                                             
   Intestine Small, Jejunum                           (60)         (60)         (60)         (59)         (60)                      
      Hyperplasia, Lymphoid                                         1 (2%)                                 1 (2%)                   
      Ulcer                                                                                   1 (2%)       1 (2%)                   
   Intestine Small, Ileum                             (59)         (60)         (59)         (60)         (58)                      
      Amyloid Deposition                                                                                   1 (2%)                   
   Liver                                              (60)         (60)         (60)         (60)         (60)                      
      Amyloid Deposition                                                                                   1 (2%)                   
      Basophilic Focus                                 3 (5%)       1 (2%)       4 (7%)       3 (5%)                                
      Clear Cell Focus                                13 (22%)      2 (3%)       5 (8%)       3 (5%)                                
      Eosinophilic Focus                              22 (37%)                  14 (23%)      8 (13%)      2 (3%)                   
      Fatty Change                                     3 (5%)                    5 (8%)       1 (2%)                                
      Hematopoietic Cell Proliferation                 2 (3%)                                              2 (3%)                   
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                 1 (2%)                   
      Mixed Cell Focus                                 6 (10%)      2 (3%)       7 (12%)      9 (15%)      1 (2%)                   
      Necrosis                                         1 (2%)       1 (2%)       2 (3%)       1 (2%)       3 (5%)                   
      Bile Duct, Cyst                                               1 (2%)                                                          
      Bile Duct, Hyperplasia                           1 (2%)                    1 (2%)                                             
      Hepatocyte, Hypertrophy                                                    1 (2%)                                             
   Mesentery                                          (5)          (1)          (3)          (3)          (2)                       
      Infiltration Cellular, Lymphocyte                                                       1 (33%)                               
      Fat, Inflammation, Chronic Active                1 (20%)      1 (100%)                  1 (33%)      1 (50%)                  
      Fat, Necrosis                                    2 (40%)                   2 (67%)      1 (33%)                               
   Pancreas                                           (60)         (60)         (60)         (60)         (60)                      
      Atrophy                                          2 (3%)                    2 (3%)                    2 (3%)                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Atypia Cellular                                               1 (2%)                                                          
      Hyperplasia                                                                             1 (2%)                                
      Necrosis                                                                   1 (2%)                                             
      Artery, Inflammation, Chronic Active                          1 (2%)                                                          
      Duct, Cyst                                                                 1 (2%)                    2 (3%)                   
   Salivary Glands                                    (60)         (60)         (60)         (60)         (60)                      
      Atrophy                                                       1 (2%)                                                          
   Stomach, Forestomach                               (60)         (60)         (60)         (60)         (60)                      
      Hyperplasia, Focal                               3 (5%)      17 (28%)      2 (3%)       3 (5%)       8 (13%)                  
      Infiltration Cellular, Mast Cell                              1 (2%)                                                          
   Stomach, Glandular                                 (60)         (60)         (60)         (60)         (60)                      
      Dysplasia                                                     1 (2%)                                                          
      Erosion                                                       5 (8%)                                                          
      Inflammation, Chronic Active, Focal                                        1 (2%)                                             
   Tooth                                              (14)                      (4)          (5)          (2)                       
      Dysplasia                                       13 (93%)                   3 (75%)      3 (60%)      1 (50%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (60)         (60)         (60)         (60)         (59)                      
      Aorta, Inflammation, Chronic Active                                                                  1 (2%)                   
   Heart                                              (60)         (60)         (60)         (60)         (60)                      
      Inflammation, Chronic Active                                               2 (3%)       1 (2%)                                
      Mineralization                                   2 (3%)                                                                       
      Artery, Inflammation, Chronic Active                                                                 1 (2%)                   
      Artery, Mineralization                                                                  1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)         (60)         (60)         (60)                      
      Accessory Adrenal Cortical Nodule                1 (2%)       1 (2%)                    1 (2%)       1 (2%)                   
      Hyperplasia                                     27 (45%)     12 (20%)     18 (30%)     20 (33%)     27 (45%)                  
      Capsule, Hyperplasia, Adenomatous                8 (13%)      7 (12%)      2 (3%)       8 (13%)      6 (10%)                  
   Adrenal Medulla                                    (59)         (60)         (55)         (60)         (60)                      
      Hyperplasia                                                                3 (5%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Islets, Pancreatic                                 (60)         (60)         (60)         (60)         (60)                      
      Hyperplasia                                     32 (53%)      3 (5%)      30 (50%)     12 (20%)      2 (3%)                   
   Parathyroid Gland                                  (56)         (51)         (49)         (56)         (52)                      
      Hyperplasia                                                                             1 (2%)                                
   Pituitary Gland                                    (58)         (58)         (56)         (55)         (53)                      
      Cyst                                             1 (2%)                                 1 (2%)                                
      Pars Distalis, Hyperplasia                       1 (2%)                                 1 (2%)                                
      Pars Intermedia, Hyperplasia                                                                         1 (2%)                   
   Thyroid Gland                                      (60)         (60)         (60)         (60)         (60)                      

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Follicular Cell, Hyperplasia                    13 (22%)      1 (2%)      15 (25%)     13 (22%)      5 (8%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (60)         (60)         (60)         (60)         (60)                      
      Granuloma Sperm                                  1 (2%)                    2 (3%)                                             
      Inflammation, Chronic Active                                  1 (2%)       1 (2%)                    1 (2%)                   
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
   Preputial Gland                                    (60)         (60)         (60)         (59)         (60)                      
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       2 (3%)       2 (3%)       3 (5%)                   
      Duct, Ectasia                                   57 (95%)     56 (93%)     58 (97%)     56 (95%)     54 (90%)                  
   Prostate                                           (59)         (59)         (60)         (60)         (60)                      
      Inflammation, Chronic Active                                                            2 (3%)       2 (3%)                   
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
   Seminal Vesicle                                    (60)         (60)         (60)         (60)         (60)                      
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)       1 (2%)                                
   Testes                                             (60)         (60)         (60)         (60)         (60)                      
      Atrophy                                          2 (3%)                                                                       
      Hypoplasia                                                    1 (2%)                                                          
      Interstitial Cell, Hyperplasia                                                                       1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)         (60)         (60)         (60)                      
      Thrombosis                                                                                           1 (2%)                   
      Erythroid Cell, Hyperplasia                                   5 (8%)       4 (7%)                    2 (3%)                   
      Myeloid Cell, Hyperplasia                        1 (2%)       1 (2%)       4 (7%)       5 (8%)       5 (8%)                   
   Lymph Node                                         (2)          (1)                       (2)          (3)                       
      Lumbar, Hyperplasia, Lymphoid                                                                        1 (33%)                  
      Mediastinal, Hyperplasia, Lymphoid               1 (50%)                                                                      
   Lymph Node, Mandibular                             (59)         (59)         (58)         (57)         (56)                      
      Hyperplasia, Lymphoid                                                      1 (2%)       1 (2%)       1 (2%)                   
   Lymph Node, Mesenteric                             (58)         (53)         (56)         (56)         (57)                      
      Hematopoietic Cell Proliferation                 2 (3%)                                              1 (2%)                   
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Hyperplasia, Plasma Cell                                                                             1 (2%)                   
      Inflammation, Chronic Active                                               1 (2%)                                             
   Spleen                                             (60)         (60)         (60)         (60)         (60)                      
      Amyloid Deposition                                                                                   1 (2%)                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Depletion Lymphoid                                            5 (8%)       1 (2%)       1 (2%)       3 (5%)                   
      Hematopoietic Cell Proliferation                 8 (13%)      7 (12%)     12 (20%)     14 (23%)     12 (20%)                  
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Thymus                                             (51)         (55)         (54)         (50)         (50)                      
      Atrophy                                          6 (12%)      5 (9%)      12 (22%)      4 (8%)       7 (14%)                  
      Epithelial Cell, Hyperplasia                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (60)         (60)         (60)         (60)         (60)                      
      Inflammation, Chronic Active                                                                         1 (2%)                   
      Ulcer                                                                                                1 (2%)                   
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                 2 (3%)                                             
      Subcutaneous Tissue, Lymphangiectasis            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                                              (1)                                                 
      Degeneration                                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (60)         (60)         (60)                      
      Hemorrhage, Acute                                                                       1 (2%)                                
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
      Neuron, Necrosis                                 1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (60)         (60)                      
      Embolus                                          1 (2%)                                                                       
      Granuloma                                                     1 (2%)                                                          
      Hemorrhage, Acute                                                                       1 (2%)                                
      Inflammation, Chronic Active                                                            2 (3%)       1 (2%)                   
      Inflammation, Suppurative                        1 (2%)                                              1 (2%)                   
      Pigmentation, Hemosiderin                                                  1 (2%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 8 (13%)      5 (8%)       3 (5%)       3 (5%)       2 (3%)                   
   Nose                                               (60)         (60)         (60)         (60)         (60)                      
      Hemorrhage, Acute                                                                       1 (2%)                                
      Inflammation, Suppurative                                                  1 (2%)                    2 (3%)                   
   Trachea                                            (60)         (60)         (60)         (60)         (60)                      
      Peritracheal Tissue, Hemorrhage, Acute                                                  1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   10                                                              
NTP Experiment-Test: 05121-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 22:04:18  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      0 MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                     
                                                                FEED RTD                                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (3)          (1)          (3)                       
      Degeneration                                                                                         1 (33%)                  
      Cornea, Inflammation, Chronic Active                                       1 (33%)      1 (100%)     1 (33%)                  
      Cornea, Necrosis                                                           1 (33%)                                            
   Harderian Gland                                    (20)         (18)         (20)         (21)         (16)                      
      Hyperplasia                                      1 (5%)                                                                       
      Inflammation, Chronic Active                                                            2 (10%)      2 (13%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)         (60)         (60)         (60)                      
      Cyst                                             6 (10%)      3 (5%)                    2 (3%)       3 (5%)                   
      Developmental Malformation                                    1 (2%)                                                          
      Hydronephrosis                                                                                       1 (2%)                   
      Infarct                                                                                 1 (2%)                                
      Inflammation, Chronic Active                     2 (3%)                                 2 (3%)       2 (3%)                   
      Necrosis                                                                   1 (2%)                    1 (2%)                   
      Nephropathy                                     58 (97%)     49 (82%)     55 (92%)     52 (87%)     43 (72%)                  
      Artery, Inflammation, Chronic Active                                                    2 (3%)                                
      Glomerulus, Amyloid Deposition                                                                       1 (2%)                   
      Renal Tubule, Hyperplasia                                                  2 (3%)                                             
   Urinary Bladder                                    (60)         (60)         (60)         (60)         (59)                      
      Inflammation, Chronic Active                     2 (3%)                                 2 (3%)       3 (5%)                   
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------